Aims & Scope

Therapeutic Advances in Musculoskeletal Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of osteoporosis and rheumatic diseases such as rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis and other related musculoskeletal diseases.

The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in rheumatology, osteoporosis and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The journal publishes review articles, original research articles, meta-analyses, systematic reviews, editorials, case reports, case series and letters to the Editor primarily.

Original research manuscripts may include laboratory, animal or human/clinical studies - all phases.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 4.1
2024 3.40

SJR (SCImago Journal Rank)

Year Value
2024 1.348

Quartile

Year Value
2024 Q1

h-index

Year Value
2024 54

Journal Rank

Year Value
2024 2903

Journal Citation Indicator

Year Value
2024 1113

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.


APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,650.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.


Quick Facts

Current Factor
4.1
First Published: 2025

SJR (SCImago Journal Rank)

SJR
1.348
First Published: 2024

Quartile

Current Quartile
Q1
First Published: 2024

Similar Journals

Top Journals in Related Fields